GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telix Pharmaceuticals Ltd (OTCPK:TLPPF) » Definitions » Other Operating Expense

Telix Pharmaceuticals (Telix Pharmaceuticals) Other Operating Expense : $4.5 Mil (TTM As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Telix Pharmaceuticals Other Operating Expense?

Telix Pharmaceuticals's Other Operating Expense for the six months ended in Dec. 2023 was $-34.9 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was $4.5 Mil.

Telix Pharmaceuticals's quarterly Other Operating Expense increased from Dec. 2022 ($15.1 Mil) to Jun. 2023 ($39.4 Mil) but then declined from Jun. 2023 ($39.4 Mil) to Dec. 2023 ($-34.9 Mil).

Telix Pharmaceuticals's annual Other Operating Expense increased from Dec. 2021 ($18.7 Mil) to Dec. 2022 ($25.7 Mil) but then declined from Dec. 2022 ($25.7 Mil) to Dec. 2023 ($4.4 Mil).


Telix Pharmaceuticals Other Operating Expense Historical Data

The historical data trend for Telix Pharmaceuticals's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telix Pharmaceuticals Other Operating Expense Chart

Telix Pharmaceuticals Annual Data
Trend Sep99 Sep00 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only 5.82 7.64 18.74 25.70 4.40

Telix Pharmaceuticals Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.73 11.03 15.11 39.42 -34.92

Telix Pharmaceuticals Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $4.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Telix Pharmaceuticals Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Telix Pharmaceuticals's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Telix Pharmaceuticals (Telix Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
55 Flemington Road, Suite 401, North Melbourne, Melbourne, VIC, AUS, 3051
Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing molecularly-targeted radiation therapy to address the unmet needs in the management of prostate, renal (kidney) and glioblastoma (brain) cancer. Geographically, it operates in Australia, the United States, Belgium, and Japan.